Both in Pharmaceuticals
Jupiter Neurosciences vs Onconetix
Over the past year JUNS returned −98.0% and ONCO returned −99.7%; their daily moves had a correlation of -0.07.
JUNS −98.0% ONCO −99.7%Growth of $1, one year, split-adjusted
| Metric | JUNS | ONCO |
|---|---|---|
| Price | $2.05 | $0.5610 |
| Market cap | $2.7M | $3.3M |
| Today | −13.50% | −4.27% |
| 1 month | −18.0% | −24.6% |
| 6 months | −93.0% | −91.2% |
| Year to date | −97.3% | −99.3% |
| 1 year | −98.1% | −99.7% |
| Revenue growth (YoY) | — | −83.9% |
| Gross margin | 86.9% | 25.1% |
| Net margin | −9380.9% | −16748.3% |
| P/E (TTM) | — | — |
| Price / sales | 41.8× | 5.1× |
| Net cash | -$6.6K | $5.8M |
| Dividend yield | — | — |
| Volatility (60d) | 903.4% | 157.0% |
| Short % of float | 6.0% | 7.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).